Lara Pippo

Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus

Maria Lucia Specchia, Chiara de Waure, Maria Rosaria Gualano et al. · BioMed Research International · 2014 · 30 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis

F. Pierotti, Ilaria Palla, M. Treur et al. · PLoS ONE · 2015 · 26 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Targeting of the HIV-1 long terminal repeat with chromomycin potentiates the inhibitory effects of a triplex-forming oligonucleotide on Sp1–DNA interactions and <i>in vitro</i> transcription

Nicoletta Bianchi, Cristina Rutigliano, Marco Passadore et al. · Biochemical Journal · 1997 · 23 citations · Full text

Life Sciences, Biology, Molecular Biology +13

Surface plasmon resonance for real-time monitoring of molecular interactions between a triple helix forming oligonucleotide and the Sp1 binding sites of human Ha-ras promoter: effects of the DNA-binding drug chromomycin.

Cristina Rutigliano, Nicoletta Bianchi, Marina Tomassetti et al. · International Journal of Oncology · 1998 · 11 citations

Medicine, Molecular Biology, Pharmacology +17

Synthesis and pharmacological characterization of constrained analogues of Vestipitant as in vitro potent and orally active NK1 receptor antagonists

Fabio Maria Sabbatini, Romano Di Fabio, Cristiana Griffante et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 11 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9